Fundraising Fox
/Companies
Sign in

Valora Therapeutics

La Jolla, US · Founded 2023 · 19 employees on LinkedIn · 3 known investors

Find your way into Valora Therapeutics

Each arrow is one introduction. Sign up to fill in the first one.

41 people can intro you to James

Ask Fabio Pucci to introduce you to James Lee

You →Fabio · together at Boundless Bio →James

Sign up to find every way you can get introduced to Valora Therapeutics

  • Your email: who you already know at Valora Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Valora Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.

BiotechHealthtech

Founders & leadership

Valora Therapeutics was founded in 2023 by Miguel Garcia-Guzman, Carolyn Bertozzi, and Jessica Stark.

MGMiguel Garcia-Guzman
Miguel Garcia-GuzmanCo-Founder, CEO & DirectorDirector at Rakuten Med
CBCarolyn Bertozzi
Carolyn BertozziScientific Co-Founder
JSJessica Stark
Jessica StarkScientific Co-Founder
JLJames Lee
James LeeVP, Business DevelopmentJames Lee has over 15 years of experience in biotech and pharmaceutical business development and R&D across oncology and other therapeutic areas. He holds a bachelor's degree in bioengineering and a master's degree in molecular biotechnology from the University of Pennsylvania, and an MBA from Columbia Business School.

Board

SH
Stefan HellerBoard director
SMSanford Madigan
Sanford MadiganDirectorManaging Partner at Avalon BioVentures

Investors · 3

Correlation Ventureslisted by Correlation VenturesSan Francisco · $100K – $4M

How we know: Correlation Ventures's portfolio page · press coverage · Not right? Tell us

AlexandriareportedPasadena

How we know: press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$13M disclosed across 1 round · 2024

▶$13MraisedJul 2024 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Miguel Garcia-GuzmanExecutive Officer, Director
  • Stefan HellerDirector
  • Sanford MadiganDirector
Offering amount
$29.2M
Amount sold
$13M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Valora Therapeutics Raises $30 Million Seed Financing — Valora Therapeuticsvaloratherapeutics.com · Nov 2024

Frequently asked questions

What does Valora Therapeutics do?
Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.
Who founded Valora Therapeutics?
Valora Therapeutics was founded by Miguel Garcia-Guzman, Carolyn Bertozzi, Jessica Stark in 2023.
Who are Valora Therapeutics's investors?
Valora Therapeutics's investors include Avalon BioVentures, Correlation Ventures, Alexandria.
How much funding has Valora Therapeutics raised?
Valora Therapeutics has disclosed $13M raised across 1 round.
Where is Valora Therapeutics headquartered?
Valora Therapeutics is headquartered in La Jolla, US.